Endogenous p53 inhibitor TIRR dissociates systemic metabolic health from oncogenic activity

Summary: It is unclear whether metabolic health corresponds to reduced oncogenesis or vice versa. We study Tudor-interacting repair regulator (TIRR), an inhibitor of p53 binding protein 1 (53BP1)-mediated p53 activation, and the physiological consequences of enhancing tumor suppressor activity. Dele...

詳細記述

書誌詳細

主要な著者:	Eva Tsaousidou, Jędrzej Chrzanowski, Pascal Drané, Grace Y. Lee, Nadine Bahour, Zeqiu Branden Wang, Shijun Deng, Zhe Cao, Kaimeng Huang, Yizhou He, Mateusz Kaminski, Dominika Michalek, Ekin Güney, Kalindi Parmar, Wojciech Fendler, Dipanjan Chowdhury, Gökhan S. Hotamışlıgil
フォーマット:	Artigo
言語:	Inglês
出版事項:	Elsevier 2024-06-01
シリーズ:	Cell Reports
主題:	CP: Cancer CP: Metabolism
オンライン･アクセス:	http://www.sciencedirect.com/science/article/pii/S221112472400665X
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!